Regeneron pinpoints gene variants that protect against obesity, launches search for new drugs

Several research groups have hunted for gene mutations that confer an increased risk of obesity in the hopes of finding new drug targets to curb the world’s expanding waistline. But scientists at Regeneron decided to take the opposite approach: They looked for genetic variants that keep people from gaining excessive amounts of weight—and they landed on one gene the company is now hoping to target with drugs.